ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001634632

venBio Global Strategic Fund II L.P.

CIK 0001634632 Name as filed on the most recent filing

Filed as venBio Global Strategic Fund II L.P. (25)

52 transaction lines · from 25 filings · filed 2017-11-13 to 2022-05-17 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

2 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2022-05-16 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 95,800 disposed 10.45 1,001,100.42 Form 4, filing 0001567619-22-011111
2022-05-13 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 35,850 disposed 10.45 374,464.00 Form 4, filing 0001567619-22-011111
2022-05-12 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 124,525 disposed 10.39 1,294,312.85 Form 4, filing 0001567619-22-010353
2022-05-11 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 17,700 disposed 10.38 183,641.04 Form 4, filing 0001567619-22-010353
2022-05-10 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 18,676 disposed 10.38 193,869.95 Form 4, filing 0001567619-22-010353
2022-05-09 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 17,600 disposed 10.37 182,582.40 Form 4, filing 0001567619-22-009850
2022-05-06 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 48,334 disposed 10.37 501,233.25 Form 4, filing 0001567619-22-009850
2022-05-05 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 20,743 disposed 10.37 215,104.91 Form 4, filing 0001567619-22-009850
2022-05-04 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 37,500 disposed 10.37 388,923.75 Form 4, filing 0001567619-22-009528
2022-05-03 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 79,475 disposed 10.37 824,433.91 Form 4, filing 0001567619-22-009528
2022-05-02 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 153,700 disposed 10.38 1,595,974.69 Form 4, filing 0001567619-22-009528
2022-04-29 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 69,230 disposed 10.38 718,662.78 Form 4, filing 0001567619-22-009203
2022-04-28 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 73,400 disposed 10.38 761,936.04 Form 4, filing 0001567619-22-009203
2022-04-27 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 47,396 disposed 10.38 491,979.96 Form 4, filing 0001567619-22-009203
2022-04-26 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 64,683 disposed 10.38 671,558.31 Form 4, filing 0001567619-22-008985
2022-04-25 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 27,668 disposed 10.39 287,404.12 Form 4, filing 0001567619-22-008985
2022-04-22 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 37,430 disposed 10.39 388,834.07 Form 4, filing 0001567619-22-008985
2022-04-21 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 62,200 disposed 10.38 645,866.14 Form 4, filing 0001567619-22-008823
2022-04-20 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 85,611 disposed 10.39 889,387.00 Form 4, filing 0001567619-22-008823
2022-04-19 Checkmate Pharmaceuticals, Inc.
CMPI 		S, Open-market sale 399,923 disposed 10.42 4,165,238.04 Form 4, filing 0001567619-22-008823
2021-04-27 Impel Neuropharma Inc
IMPL 		P, Open-market purchase 450,000 acquired 15.00 6,750,000.00 Form 4, filing 0000905148-21-000408
2020-08-11 Checkmate Pharmaceuticals, Inc.
CMPI 		P, Open-market purchase 200,000 acquired 15.00 3,000,000.00 Form 4, filing 0000905148-20-000880
2020-07-21 ALX Oncology Holdings Inc
ALXO 		P, Open-market purchase 850,000 acquired 19.00 16,150,000.00 Form 4, filing 0000905148-20-000827
2020-07-21 ALX Oncology Holdings Inc
ALXO 		P, Open-market purchase 3,000 acquired 19.00 57,000.00 Form 4, filing 0000905148-20-000827
2020-07-06 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 4,603 disposed 33.83 155,721.33 Form 4, filing 0000905148-20-000773
2020-07-02 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 3,800 disposed 33.63 127,805.40 Form 4, filing 0000905148-20-000773
2020-07-01 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 108,064 disposed 34.45 3,723,010.12 Form 4, filing 0000905148-20-000773
2020-03-06 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 1,800 disposed 23.79 42,830.82 Form 4, filing 0001012975-20-000291
2020-03-05 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 8,500 disposed 23.53 200,010.95 Form 4, filing 0001012975-20-000291
2020-03-04 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 35,650 disposed 23.81 848,765.90 Form 4, filing 0001012975-20-000291
2020-03-03 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 6,401 disposed 23.00 147,198.68 Form 4, filing 0001012975-20-000275
2020-03-02 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 10,297 disposed 23.06 237,459.12 Form 4, filing 0001012975-20-000275
2020-02-28 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 5,100 disposed 21.30 108,652.44 Form 4, filing 0001012975-20-000275
2020-02-27 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 1,781 disposed 22.54 40,143.74 Form 4, filing 0001012975-20-000267
2020-02-26 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 2,523 disposed 22.44 56,615.36 Form 4, filing 0001012975-20-000267
2020-02-25 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 1,600 disposed 23.67 37,876.00 Form 4, filing 0001012975-20-000267
2020-02-12 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 6 disposed 27.14 162.84 Form 4, filing 0001012975-20-000119
2020-02-11 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 2,184 disposed 27.05 59,068.03 Form 4, filing 0001012975-20-000119
2020-02-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 7,836 disposed 27.08 212,168.32 Form 4, filing 0001012975-20-000119
2020-02-06 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 6,102 disposed 27.03 164,954.76 Form 4, filing 0001012975-20-000115
2020-02-05 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 28,608 disposed 25.99 743,547.67 Form 4, filing 0001012975-20-000113
2020-02-04 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 53,731 disposed 25.65 1,378,178.66 Form 4, filing 0001012975-20-000113
2020-01-13 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 494,000 disposed 20.23 9,993,620.00 Form 4, filing 0001012975-20-000033
2020-01-08 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 15,677 disposed 19.86 311,354.63 Form 4, filing 0001012975-20-000029
2020-01-07 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 31,000 disposed 20.17 625,149.10 Form 4, filing 0001012975-20-000022
2020-01-06 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 42,221 disposed 19.64 829,380.88 Form 4, filing 0001012975-20-000022
2020-01-03 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 12,498 disposed 19.30 241,213.90 Form 4, filing 0001012975-20-000013
2020-01-02 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 23,000 disposed 19.94 458,507.30 Form 4, filing 0001012975-20-000013
2019-12-31 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 14,324 disposed 23.96 343,258.90 Form 4, filing 0001012975-20-000009
2019-06-24 Akero Therapeutics, Inc.
AKRO 		P, Open-market purchase 250,000 acquired 16.00 4,000,000.00 Form 4, filing 0001012975-19-000449

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. venBio Global Strategic Fund II L.P., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001634632

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.